Assessment of a mouse xenograft model of primary colorectal cancer with special reference to perfluorooctane sulfonate.

Wimsatt, Jeffrey H; Montgomery, Caitlin; Thomas, Laurel S; Savard, Charity; Tallman, Rachel; Innes, Kim; Jrebi, Nezar

Wimsatt, Jeffrey H; Montgomery, Caitlin; Thomas, Laurel S; Savard, Charity; Tallman, Rachel; Innes, Kim; Jrebi, Nezar.

Afiliação

Wimsatt JH; Department of Medicine, West Virginia University, Morgantown, WV, United States of America.
Montgomery C; Department of Epidemiology, West Virginia University, Morgantown, WV, United States of America.
Thomas LS; Department of Medicine, West Virginia University, Morgantown, WV, United States of America.
Savard C; Department of Epidemiology, West Virginia University, Morgantown, WV, United States of America.
Tallman R; Department of Medicine, West Virginia University, Morgantown, WV, United States of America.
Innes K; Department of Medicine, West Virginia University, Morgantown, WV, United States of America.
Jrebi N; Department of Medicine, West Virginia University, Morgantown, WV, United States of America.

PeerJ ; 6: e5602, 2018.

Article em En | MEDLINE | ID: mdl-30405966

Palavras-chave

CRC; Model selection; NOD SCID Gamma mouse; NSG mouse; PDX; PFOS; Patient derived xenograft; Perfluorooctane sulfonate; Treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: PeerJ Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google